Alopecia is a broad medical term for hair loss, and whether it qualifies as a “disease” depends on the type. Some forms of alopecia are diseases in their own right, driven by the immune system attacking hair follicles. Others are better described as a gradual, genetically influenced process or a symptom of something else entirely. The word “alopecia” alone simply means the absence or loss of hair in an area where it would normally grow.
Understanding the distinction matters because it changes what causes the hair loss, whether it’s reversible, and how it’s treated.
Alopecia as a Term vs. a Disease
In medical literature, alopecia is recognized as a sign or symptom that can arise from many different causes. It can be localized to one spot or spread across the scalp, temporary or permanent. Broadly, hair loss falls into two categories: nonscarring (the most common) and scarring. Nonscarring types leave the hair follicle intact, meaning regrowth is possible. Scarring types destroy the follicle permanently.
So when someone says “I have alopecia,” they could be describing anything from a small bald patch to complete body hair loss. The specific type determines whether it’s classified as a disease, a genetic condition, or a reaction to something else like medication, stress, or nutritional deficiency.
Alopecia Areata: The Autoimmune Disease
Alopecia areata is the form most people mean when they ask if alopecia is a disease, and the answer here is clearly yes. It is a chronic autoimmune disease affecting roughly 2% of the global population. It typically appears as sudden, round patches of hair loss on the scalp, though it can progress to total scalp hair loss or even loss of all body hair.
In alopecia areata, the immune system loses the ability to recognize hair follicles as “self.” A specific type of immune cell accumulates around the base of the hair follicle and attacks it. This attack is driven by signaling molecules that create a self-reinforcing loop: the immune cells release compounds that cause inflammation, which in turn recruits more immune cells. The hair follicle essentially loses its natural immune protection, becoming a target.
One detail researchers have identified is that pigment-producing cells within the follicle may be part of what triggers the attack. This could explain why alopecia areata sometimes spares gray or white hairs while targeting pigmented ones, and why some people notice their first patches of regrowth come in white before darkening.
Alopecia areata affects men, women, and children. It can start at any age, though onset during childhood and adolescence is common. The course is unpredictable. Some people experience a single episode with full regrowth, while others cycle through repeated episodes or progress to more extensive loss.
Androgenetic Alopecia: Genetic, Not Autoimmune
Pattern hair loss, the receding hairline and thinning crown in men or widening part in women, is technically called androgenetic alopecia. It affects approximately 50% of both men and women over a lifetime. This is not an autoimmune disease. It’s a genetically predetermined response to hormones.
People with this type of hair loss produce higher levels of a potent form of testosterone in their scalp, along with more receptors for it in the areas that thin. This hormone gradually shrinks susceptible hair follicles, turning thick terminal hairs into fine, nearly invisible ones. The process depends on genes inherited from both parents, and it only begins after puberty when hormone levels rise.
Whether you call this a “disease” is partly a matter of framing. Medically, it’s classified as a disorder, a condition with a clear biological mechanism. But it doesn’t involve immune system malfunction, infection, or tissue destruction. The follicles miniaturize rather than die, which is why treatments that block the hormonal pathway can slow or partially reverse the process.
Scarring Alopecia: Permanent Follicle Destruction
Scarring alopecia represents a group of conditions where inflammation destroys the hair follicle and replaces it with scar tissue. These are diseases by any definition. The inflammation targets the middle portion of the follicle where stem cells and oil glands sit, both of which are essential for growing new hair. Once that area is destroyed, the loss is permanent.
Several distinct conditions fall under this umbrella, each with different inflammatory patterns. Some involve the body’s own immune system attacking the follicle, while others stem from infections or other inflammatory processes. Early diagnosis is important because treatment focuses on stopping the spread of inflammation to preserve remaining hair, since regrowth from destroyed follicles isn’t possible.
How Alopecia Is Diagnosed
Dermatologists start by determining whether the hair loss is scarring or nonscarring, which guides everything that follows. A physical exam can reveal a lot: the pattern of loss, whether the scalp skin looks normal or inflamed, and the condition of remaining hairs.
A hair pull test, where the doctor gently tugs a small group of hairs to see how easily they come out, helps identify active hair loss. Trichoscopy, essentially a magnified view of the scalp, can reveal telltale signs like “exclamation mark” hairs (short hairs that taper at the base) in alopecia areata or miniaturized follicles in pattern hair loss. When the diagnosis is unclear, a small scalp biopsy can be taken, ideally from the edge of an active patch rather than the center, to examine the follicles under a microscope.
The Psychological Weight of Hair Loss
Regardless of whether a specific type of alopecia is technically classified as a disease, the emotional impact is real and well documented. In one study of 75 people with alopecia areata, 66.7% had depression and 73.3% had anxiety. Other studies have found depression rates between 61% and 74% in people with the condition. These aren’t small numbers, and they hold across different research groups and populations.
Hair loss affects how people see themselves and how they believe others see them. The unpredictability of alopecia areata in particular, where hair can fall out and regrow without warning, adds a layer of psychological stress that goes beyond the physical symptom.
Treatment Options by Type
For alopecia areata, treatment has changed significantly in recent years. Three oral medications that work by interrupting the immune signaling loop have received FDA approval: one in 2022, a second in 2023 (approved for patients 12 and older), and a third in 2024. These drugs block the specific chemical pathways that drive the immune attack on hair follicles. In clinical trials, they produced significant hair regrowth in people with severe cases. Before these approvals, treatment options were limited to steroid injections, topical immune therapies, and other approaches with inconsistent results.
For androgenetic alopecia, treatments focus on blocking the hormone responsible for follicle miniaturization or stimulating hair growth directly. These work best when started early, before significant miniaturization has occurred.
Scarring alopecia treatment centers on controlling inflammation as quickly as possible to prevent further follicle destruction. The specific approach depends on which type of scarring alopecia is involved. Hair transplantation may be an option once the condition has been stable and inactive for a sustained period.